BOSTON SCIENTIFIC CORPORATION Long-Lived Assets
BOSTON SCIENTIFIC CORPORATION (BSX) had Long-Lived Assets of $30.24 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-08-03
- 2026-06-30: Long-Lived Assets $30.24B.
- 2026-03-31: Long-Lived Assets $30.21B.
- 2025-12-31: Long-Lived Assets $29.80B.
- 2025-09-30: Long-Lived Assets $29.66B.
| Period end | Long-Lived Assets |
|---|---|
| 2026-06-30 | $30.24B 10-Q · filed 2026-08-03 |
| 2026-03-31 | $30.21B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $29.80B 10-Q · filed 2026-08-03 |
| 2025-09-30 | $29.66B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $29.29B 10-Q · filed 2025-08-01 |
| 2025-03-31 | $27.74B 10-Q · filed 2025-05-01 |
| 2024-12-31 | $27.52B 10-K · filed 2026-02-17 |
| 2023-12-31 | $23.69B 10-K · filed 2025-02-18 |
| 2022-12-31 | $21.65B 10-K · filed 2024-02-20 |
| 2021-12-31 | $20.80B 10-K · filed 2023-02-23 |
| 2020-12-31 | $18.41B 10-K · filed 2022-02-23 |
| 2019-12-31 | $20.48B 10-K · filed 2022-02-23 |
| 2018-12-31 | $16.06B 10-K · filed 2021-02-23 |
| 2017-12-31 | $14.53B 10-K · filed 2020-02-25 |
| 2016-12-31 | $14.19B 10-K · filed 2019-02-19 |
| 2015-12-31 | $14.16B 10-K · filed 2018-02-20 |
| 2014-12-31 | $13.01B 10-K · filed 2017-02-23 |
| 2013-12-31 | $13.19B 10-K · filed 2016-02-24 |
| 2012-12-31 | $13.83B 10-K · filed 2015-02-25 |
| 2011-12-31 | $17.90B 10-K · filed 2014-02-26 |
| 2010-12-31 | $18.23B 8-K · filed 2013-05-29 |
| 2009-12-31 | $20.32B 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |